Circovirus

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.

Circovirus control
Circovirus

Circovirus control

  • 5 minutes

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.

BOEHRINGER INGELHEIM ANIMAL HEALTH HAS BEEN SUPPORTING INDEPENDENT RESEARCH ON PCV2 FOR ONE DECADE
Circovirus

BOEHRINGER INGELHEIM ANIMAL HEALTH HAS BEEN SUPPORTING INDEPENDENT RESEARCH ON PCV2 FOR ONE DECADE

  • 10 minutes

Ingelheim/Germany, 09 February, 2017 – For the tenth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past ten years, 29 research projects have been awarded with € 25,000.

MOST SUCCESSFUL ANIMAL HEALTH VACCINE OF ALL TIME REACHES MILESTONE OF TWO BILLION PIGS BEING PROTECTED
Circovirus

MOST SUCCESSFUL ANIMAL HEALTH VACCINE OF ALL TIME REACHES MILESTONE OF TWO BILLION PIGS BEING PROTECTED

  • 10 minutes

Worldwide over two billion pigs have been protected against Porcine Circovirus Disease using Ingelvac CircoFLEX® 

The vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine1

It can be of your interest
THE PIGLET’S LUNGS – FULLY ONLY MATURED BY 14 DAYS OF AGE
Others

THE PIGLET’S LUNGS – FULLY ONLY MATURED BY 14 DAYS OF AGE

  • 5 minutes

In normally developing suckling pigs, although a piglet breathes from soon after birth, the lung’s tissue increases its size and function during the first 14 days of life. The oxygen transfer continually improves during this time.

 Others

PROVEN AND RELIABLE EFFICACY: 4 BILLION PIGS PROTECTED AGAINST M. HYO, PCV 2 AND PRRS WITH VACCINES FROM BOEHRINGER INGELHEIM ANIMAL HEALTH

  • 5 minutes

Ingelheim, Germany, 13 December 2016  – Having reached the milestone of 1 billion doses sold since launch, yet another vaccine of Boehringer Ingelheim Animal Health crosses a significant threshold making it one of the leading vaccines for the control of Mycoplasma hyopneumoniae globally(1).